Pharmaceutical giant GlaxoSmithKline said its 5-year turnaround strategy, which has included painful restructuring and layoffs, was validated Wednesday when the company reported that worldwide drug sales grew 2 percent in the second quarter.
http://blogs.newsobserver.com/business/gsk-sales-rise-but-fallout-from-china-scandal-looms
http://blogs.newsobserver.com/business/gsk-sales-rise-but-fallout-from-china-scandal-looms
